Moderna Historical Income Statement

MRNA
 Stock
  

USD 159.56  4.02  2.58%   

Historical analysis of Moderna income statement accounts such as Earning Before Interest and Taxes EBIT of 14.3 B can show how well Moderna performed in making a profits. Evaluating Moderna income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Moderna's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Moderna latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Moderna is a good buy for the upcoming year.
Additionally, see Stocks Correlation.
  
Refresh

Moderna Net Income

13.17 Billion

About Moderna Income Statement Analysis

Moderna Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Moderna shareholders. The income statement also shows Moderna investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Moderna Income Statement Chart

Moderna Income Statement is one of the three primary financial statements used for reporting Moderna's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Moderna revenue and expense. Moderna Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Moderna Consolidated Income is projected to increase significantly based on the last few years of reporting. The past year's Consolidated Income was at 12.2 Billion. The current year Earning Before Interest and Taxes EBIT is expected to grow to about 14.3 B, whereas Preferred Dividends Income Statement Impact is forecasted to decline to about 19.1 M.

Consolidated Income

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income Available to Non-controlling Interests.

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding Income Tax Expense and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Moderna financial statement analysis. It represents the amount of money remaining after all of Moderna operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends Income Statement Impact.

Revenues

Revenues refers to the total amount of money received by Moderna for goods sold or services provided during a certain time period. It also includes all of Moderna sales as well as any other increase in Moderna equity.Revenues are reported on Moderna income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Most accounts from Moderna income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Moderna current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Additionally, see Stocks Correlation.Moderna Consolidated Income is projected to increase significantly based on the last few years of reporting. The past year's Consolidated Income was at 12.2 Billion. The current year Earning Before Interest and Taxes EBIT is expected to grow to about 14.3 B, whereas Preferred Dividends Income Statement Impact is forecasted to decline to about 19.1 M.
 2019 2020 2021 2022 (projected)
Revenues USD60 M803 M18.47 B19.93 B
Revenues60 M803 M18.47 B19.93 B

Moderna income statement Correlations

Moderna Account Relationship Matchups

Moderna income statement Accounts

201720182019202020212022 (projected)
Consolidated Income(255.92 M)(384.73 M)(514 M)(747 M)12.2 B13.17 B
Earning Before Interest and Taxes EBIT(256 M)(384.41 M)(515 M)(744 M)13.29 B14.33 B
Earning Before Interest and Taxes USD(256 M)(384.41 M)(515 M)(744 M)13.29 B14.33 B
Gross Profit205.82 M135.07 M60 M795 M15.85 B17.11 B
Net Income(255.92 M)(384.73 M)(514 M)(747 M)12.2 B13.17 B
Net Income Common Stock(269.84 M)(401.86 M)(514 M)(747 M)12.2 B13.17 B
Net Income Common Stock USD(269.84 M)(401.86 M)(514 M)(747 M)12.2 B13.17 B
Operating Expenses475.18 M548.33 M606 M1.56 B2.56 B2.76 B
Operating Income(269.36 M)(413.27 M)(546 M)(763 M)13.3 B14.35 B
Revenues205.82 M135.07 M60 M803 M18.47 B19.93 B
Revenues USD205.82 M135.07 M60 M803 M18.47 B19.93 B
Research and Development Expense410.46 M454.08 M496 M1.37 B1.99 B2.15 B
Selling General and Administrative Expense64.72 M94.25 M110 M188 M567 M611.76 M
Weighted Average Shares64.5 M81.11 M331 M381 M403 M339.6 M
Weighted Average Shares Diluted64.5 M81.11 M331 M381 M431 M357.04 M
Income Tax Expense(80 K)326 K(1,000 K)3 M1.08 B1.17 B

Moderna Investors Sentiment

The influence of Moderna's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Moderna. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Moderna's public news can be used to forecast risks associated with investment in Moderna. The trend in average sentiment can be used to explain how an investor holding Moderna can time the market purely based on public headlines and social activities around Moderna. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Moderna's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Moderna's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Moderna's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Moderna.

Moderna Implied Volatility

    
  82.42  
Moderna's implied volatility exposes the market's sentiment of Moderna stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Moderna's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Moderna stock will not fluctuate a lot when Moderna's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Moderna in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Moderna's short interest history, or implied volatility extrapolated from Moderna options trading.

Current Sentiment - MRNA

Moderna Investor Sentiment

Most of Macroaxis users are now bullish on Moderna. What is your trading attitude regarding investing in Moderna? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Moderna using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Moderna information on this page should be used as a complementary analysis to other Moderna's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Moderna Stock analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
2.02
Market Capitalization
61.9 B
Quarterly Revenue Growth YOY
2.13
Return On Assets
0.5
Return On Equity
1.4
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.